Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon
Thumbnail

‘Unacceptable’ coverage losses drive hospital, doctor opposition to ACA replacement bill

Hospital groups, the American Medical Association (AMA) and several other healthcare organizations said they can’t support the American Health Care Act (ACHA), the Republican-sponsored replacement for the Affordable Care Act (ACA), after an estimate that 24 million more people would become uninsured by 2026 if the bill becomes law. 

AHIMA releases guidelines for inclusion of LGBT patients

The American Health Information Management Association (AHIMA) has released a brief of guidelines for health information management professionals and clinicians on improving inclusion for patients in the LGBTQ community, covering multiple sexual orientations and gender identities.

Thumbnail

Seema Verma confirmed as CMS administrator

The U.S. Senate has confirmed President Donald Trump’s selection for CMS administrator, Seema Verma, MPH, by a 55-43 vote, with Democrats largely opposing her nomination while the healthcare industry pledged to work with her. 

Thumbnail

CBO on ACA replacement: 24 million more uninsured, premiums lower by 2026

The Congressional Budget Office (CBO) estimates the gains in insurance coverage from the Affordable Care Act (ACA) would be wiped out if its Republican-sponsored replacement, the American Health Care Act (AHCA), is enacted. 

Thumbnail

HHS Secretary Price encourages states to use ACA waivers for reinsurance, high-risk pools

While supporting the current proposal to repeal and replace the Affordable Care Act (ACA), HHS Secretary Tom Price, MD, encouraged states to submit more “innovation waivers” as allowed under the ACA to form their own reinsurance programs and fund pools to cover high-cost patients.

‘Patients before politics': AMA launches site focused on ACA repeal debate

After coming out in opposition to the American Health Care Act (AHCA), the Republican-sponsored plan to replace the Affordable Care Act (ACA), the American Medical Association (AMA) is stepping up efforts to get physicians involved in the legislative conversation through a new website.

Thumbnail

Anthem supports ACA replacement legislation

The second-largest health insurer in the U.S., Anthem, has come out in support of provisions in the Republican-sponsored replacement for the Affordable Care Act (ACA), going against the opposition expressed by the American Medical Association (AMA) and concerns from its own industry group. 

The potential impact of the Republican ACA replacement

Health policy analyses predict 15 million people could lose their health coverage and 30 million could be subject to surcharges on top of premiums if the Republican-sponsored American Health Care Act (AHCA) goes into effect.

Displaying 2057 - 2064 of 2772

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup